Surgery, Not Pharma, Is Biggest Healthcare Cost Worry: Gawande

By | June 22, 2018

  • June 22, 2018 at 3:46 pm
    Agent says:
    Like or Dislike:
    Thumb up 4
    Thumb down 0

    Surgeons are paid to operate. They are like Auto mechanics and the patient is the car. My wife had 5 back operations and the net result is almost no relief from her constant pain.

  • June 22, 2018 at 9:30 pm
    cassandra says:
    Like or Dislike:
    Thumb up 2
    Thumb down 0

    Agent…for once we agree on something. I feel for your wife having to live with chronic pain myself. Sympathy and regards to you both.

  • June 23, 2018 at 6:56 am
    PolarBeaRepeal says:
    Like or Dislike:
    Thumb up 1
    Thumb down 0

    This is enlightening, although I had discussed this with others working on lowering HI costs. The last discussion was regarding pharma costs, and the rapidly rising costs of life-saving/ altering meds. Surgery, is another element of health care costs that needs to be addressed aggressively, although it is less likely to be needed, in some cases, in the future. The Trump administration has recently taken steps to lower the costs of drugs. One thing the Federal govt can do is to ‘lower barriers to entry’ in the medical profession, to create competition and eliminate backlogs for treatment that are prevalent in countries with Social Insurance programs (Single Payer system). By lower barriers to entry, I do NOT mean lower medical school and licensing standards… I mean financial aid and tax credit incentives, etc.

    • June 25, 2018 at 7:56 am
      Ron says:
      Like or Dislike:
      Thumb up 0
      Thumb down 1

      Against my better judgement I will attempt to have an honest and civil debate. For thwe record, I do not disagree with you. I am just looking for some clarification.

      1. When you say using financial aid and tax credits to reduce barriers of entry, does that mean using taxpayer dollars to assist a private company to be more profitable?

      2. If we do this, do we put restrictions on prices or do we just cross our fingers and hope competition takes care of that?

      3. Would you also advocate reducing the length of time a patent grants exclusive rights to the patent holder?



Add a Comment

Your email address will not be published. Required fields are marked *

*